AI Science Tracker

Bayesian models prioritize compounds for Schistosoma mansoni assays

Collaborations Pharmaceuticals · 12 Jan 2021 · medicine

Discovery

Bayesian models prioritize compounds for Schistosoma mansoni assays

Eight stage/time-specific Bayesian classifiers trained on historical phenotypic measurements guided prospective selection of predicted active and inactive commercial compounds. In-vitro assays reported 48% and 34% hit fractions for somules and adults, followed by triage of five compounds. The selected-set fractions are not unbiased head-to-head screening rates; no animal cure, clinical mechanism, safety or efficacy is established.

Technology: Bayesian classifiers

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Primary article reports prospective somule/adult screens and prioritized compounds after triage.
  • Still unknown: Compound-specific prior evidence and complete supplementary access remain open; no clinical inference.
  • AI role: Stage/time-specific Bayesian models guided selection of assay compounds, with human curation and triage.

Evidence sources: https://doi.org/10.1021/acsinfecdis.0c00754

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: PMC-indexed primary text; PubMed primary metadata. Material checked for the specific claims stated in the record..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.